Pelion Healthcare Group: 25 years in the healthcare business
A company built from the ground up, present on two European markets and in all segments of pharmaceutical distribution, with the status of a listed company, operating the largest pharmacy chain in Poland, top player in distribution to pharmacies and leader of supply to hospitals; employing over nine thousand people and generating annual revenue of approximately PLN 8bn − those are the achievements of which Pelion Healthcare Group can boast after 25 years on the market.
As a company built on the basis of Polish capital, Pelion has been a significant contributor to Poland’s economy for 25 years. Pelion’s history is a history of development from a small, local wholesaler supplying only a few pharmacies, to one of the largest operators on the Polish and Lithuanian healthcare markets, providing services to patients, pharmacies, hospitals and manufacturers, pioneering and leading innovative e-health solutions. Every year, the company records an increase in sales and number of clients. The drug distribution system used by Pelion is among the most developed in Europe, ensuring closed, fully sealed and safe transport of medicines from manufacturer to patient.
Pelion Healthcare Group comprises over 170 entities. Pelion’s core operations are focused within four business lines as part of which, through its subsidiaries, it serves over 10 thousand pharmacies, cooperates with 850 drug manufacturers, leads the domestic market of hospital supplies, providing medicines to 80% of all hospitals in Poland, manages the largest pharmacy chain on the Polish market and provides manufacturers with comprehensive logistics support.
Pelion Healthcare Group’s 25 years of market presence has been the time of building solid foundations for the company, which in 2015 was ranked 32nd in the list of 500 Largest Polish Businesses published by Rzeczpospolita.
Pelion’s objective for the coming years is to continue to sustainably develop its services for patients, pursuing its mission expressed in the words ‘Long and quality life’. Pelion’s key value is the wellness of patients, which is why it focuses fully on patients and their needs, providing them with innovative and comprehensive healthcare solutions. Pelion also aims to serve patients with support throughout the process of pharmacotherapy, as well as with expert knowledge, modern solutions in disease prevention and treatment and access to a wide range of affordable medicines.
For further information, please contact:
Pelion S.A. Press Office
Phone: (+48 42) 200 75 94
Fax: (+48 42) 200 75 35
Email: biuro_prasowe@pelion.eu
Pelion S.A. has operated on the market for twenty-five years, starting out as a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its flotation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare is one of the largest groups operating in the healthcare markets in Poland and Lithuania. It provides services across all market segments (wholesale, retail sales and sales to hospitals), targeted at individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Company’s operations, which are conducted by PGF S.A. and Pharmapoint Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (hospital sales), CEPD N.V. (retail sales), and Pharmalink Sp. z o.o. (services for manufacturers).
Pelion Healthcare Group comprises over 170 entities. Pelion’s core operations are focused within four business lines as part of which, through its subsidiaries, it serves over 10 thousand pharmacies, cooperates with 850 drug manufacturers, leads the domestic market of hospital supplies, providing medicines to 80% of all hospitals in Poland, manages the largest pharmacy chain on the Polish market and provides manufacturers with comprehensive logistics support.
Pelion Healthcare Group’s 25 years of market presence has been the time of building solid foundations for the company, which in 2015 was ranked 32nd in the list of 500 Largest Polish Businesses published by Rzeczpospolita.
Pelion’s objective for the coming years is to continue to sustainably develop its services for patients, pursuing its mission expressed in the words ‘Long and quality life’. Pelion’s key value is the wellness of patients, which is why it focuses fully on patients and their needs, providing them with innovative and comprehensive healthcare solutions. Pelion also aims to serve patients with support throughout the process of pharmacotherapy, as well as with expert knowledge, modern solutions in disease prevention and treatment and access to a wide range of affordable medicines.
For further information, please contact:
Pelion S.A. Press Office
Phone: (+48 42) 200 75 94
Fax: (+48 42) 200 75 35
Email: biuro_prasowe@pelion.eu
Pelion S.A. has operated on the market for twenty-five years, starting out as a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its flotation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare is one of the largest groups operating in the healthcare markets in Poland and Lithuania. It provides services across all market segments (wholesale, retail sales and sales to hospitals), targeted at individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Company’s operations, which are conducted by PGF S.A. and Pharmapoint Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (hospital sales), CEPD N.V. (retail sales), and Pharmalink Sp. z o.o. (services for manufacturers).
